Mark L. Berch

Array ( [id] => 4101488 [patent_doc_number] => 06066641 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Aryl thioxanthines' [patent_app_type] => 1 [patent_app_number] => 8/860680 [patent_app_country] => US [patent_app_date] => 1997-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8534 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066641.pdf [firstpage_image] =>[orig_patent_app_number] => 860680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770503 [patent_doc_number] => 05849734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Muscarinic receptor ligands' [patent_app_type] => 1 [patent_app_number] => 8/872935 [patent_app_country] => US [patent_app_date] => 1997-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7633 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849734.pdf [firstpage_image] =>[orig_patent_app_number] => 872935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3952301 [patent_doc_number] => 05955611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Process for preparing sildenafil' [patent_app_type] => 1 [patent_app_number] => 8/869532 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7335 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955611.pdf [firstpage_image] =>[orig_patent_app_number] => 869532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109172 [patent_doc_number] => 06057313 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Glutamate (ampa/kainate) receptor antagonists: N-substituted fused azacycloalkylquinoxalinediones' [patent_app_type] => 1 [patent_app_number] => 8/869515 [patent_app_country] => US [patent_app_date] => 1997-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11146 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057313.pdf [firstpage_image] =>[orig_patent_app_number] => 869515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352702 [patent_doc_number] => 06214992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation' [patent_app_type] => 1 [patent_app_number] => 8/868641 [patent_app_country] => US [patent_app_date] => 1997-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16514 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214992.pdf [firstpage_image] =>[orig_patent_app_number] => 868641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4074554 [patent_doc_number] => 05965555 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Xanthine compounds having terminally animated alkynol side chains' [patent_app_type] => 1 [patent_app_number] => 8/866347 [patent_app_country] => US [patent_app_date] => 1997-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21867 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965555.pdf [firstpage_image] =>[orig_patent_app_number] => 866347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3969349 [patent_doc_number] => 05886171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => '3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones' [patent_app_type] => 1 [patent_app_number] => 8/864529 [patent_app_country] => US [patent_app_date] => 1997-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6638 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886171.pdf [firstpage_image] =>[orig_patent_app_number] => 864529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4064469 [patent_doc_number] => 05866566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Derivatives of 10, 11-Dihydro-10-OXO-5H-Dibenz/B,F/Azepine-5-carboxamide' [patent_app_type] => 1 [patent_app_number] => 8/862196 [patent_app_country] => US [patent_app_date] => 1997-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4105 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866566.pdf [firstpage_image] =>[orig_patent_app_number] => 862196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4058402 [patent_doc_number] => 05863921 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Purine and guanine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/849443 [patent_app_country] => US [patent_app_date] => 1997-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7614 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863921.pdf [firstpage_image] =>[orig_patent_app_number] => 849443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045550 [patent_doc_number] => 05912252 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Purine and guanine derivatives as PNP inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/849438 [patent_app_country] => US [patent_app_date] => 1997-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8617 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912252.pdf [firstpage_image] =>[orig_patent_app_number] => 849438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355727 [patent_doc_number] => 06218379 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Tricyclic carbacephems' [patent_app_type] => 1 [patent_app_number] => 8/857280 [patent_app_country] => US [patent_app_date] => 1997-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22112 [patent_no_of_claims] => 124 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 694 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218379.pdf [firstpage_image] =>[orig_patent_app_number] => 857280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994949 [patent_doc_number] => 05892035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Process for preparing N,N\'-difluorodiazoniabicycloalkane salt, intermediate therefor' [patent_app_type] => 1 [patent_app_number] => 8/809932 [patent_app_country] => US [patent_app_date] => 1997-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12239 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892035.pdf [firstpage_image] =>[orig_patent_app_number] => 809932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4028096 [patent_doc_number] => 05883247 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Preparation of cephem and isooxacephem derivatives' [patent_app_type] => 1 [patent_app_number] => 8/856070 [patent_app_country] => US [patent_app_date] => 1997-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6672 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/883/05883247.pdf [firstpage_image] =>[orig_patent_app_number] => 856070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772798 [patent_doc_number] => 05807850 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Therapeutic agent for osteoporosis and triazepine compound' [patent_app_type] => 1 [patent_app_number] => 8/836243 [patent_app_country] => US [patent_app_date] => 1997-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38243 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807850.pdf [firstpage_image] =>[orig_patent_app_number] => 836243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809056 [patent_doc_number] => 05831085 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof' [patent_app_type] => 1 [patent_app_number] => 8/845735 [patent_app_country] => US [patent_app_date] => 1997-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5072 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831085.pdf [firstpage_image] =>[orig_patent_app_number] => 845735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4008604 [patent_doc_number] => 05888998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => '2-oxo-1-azetidine sulfonic acid derivatives as potent .beta.-lactamase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/840608 [patent_app_country] => US [patent_app_date] => 1997-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8461 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888998.pdf [firstpage_image] =>[orig_patent_app_number] => 840608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3966566 [patent_doc_number] => 05885986 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments' [patent_app_type] => 1 [patent_app_number] => 8/817665 [patent_app_country] => US [patent_app_date] => 1997-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21350 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885986.pdf [firstpage_image] =>[orig_patent_app_number] => 817665 [rel_patent_id] =>[rel_patent_doc_number] =>)